Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025)

Guardant Health's (GH) quarterly Asset Writedowns and Impairment came in at $13.6 million in Q4 2025, up 171.64% quarter-over-quarter from $5.0 million in Q1 2025.

Guardant Health (GH) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends

Guardant Health has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $13.6 million for Q4 2025.

  • Asset Writedowns and Impairment for Q4 2025 came in at $13.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $13.6 million (up 171.64% YoY), and the FY2025 annual result was $18.6 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment came in at $13.6 million for Q4 2025 at Guardant Health, up from $5.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $23.6 million in Q2 2023 to a low of $5.0 million in Q1 2025.
  • The 3-year median for Asset Writedowns and Impairment is $5.5 million (2023), against an average of $10.6 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Guardant Health 17.09 Bn 15.99 Bn 196.75 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 13.58 Mn
Dec 31, 2025 13.58 Mn
Mar 31, 2025 5.00 Mn
Mar 31, 2025 5.00 Mn
Jun 30, 2023 23.57 Mn
Jun 30, 2023 23.57 Mn
Mar 31, 2023 5.49 Mn
Mar 31, 2023 5.49 Mn
Sep 30, 2022 5.26 Mn
Sep 30, 2022 5.26 Mn